J.P. Morgan Private Wealth Advisors LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 60 filers reported holding UROGEN PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2019$537,000
-12.5%
14,543
+2.1%
0.00%
-25.0%
Q4 2018$614,000
-19.9%
14,250
-12.3%
0.00%0.0%
Q3 2018$767,000
+25.7%
16,250
+32.7%
0.00%
+33.3%
Q2 2018$610,000
+0.2%
12,2500.0%0.00%
-25.0%
Q1 2018$609,000
+33.6%
12,2500.0%0.00%
+33.3%
Q4 2017$456,000
+18.1%
12,2500.0%0.00%0.0%
Q3 2017$386,000
+74.7%
12,2500.0%0.00%
+50.0%
Q2 2017$221,00012,2500.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,155,862$38,571,00011.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 849,478$28,347,0004.49%
Horton Capital Management, LLC 108,670$3,626,0003.53%
Prosight Management, LP 217,686$7,264,0003.19%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$98,598,0002.35%
Phoenix Holdings Ltd. 834,739$27,663,0001.16%
SHIKIAR ASSET MANAGEMENT INC 67,025$2,237,0000.74%
MEITAV INVESTMENT HOUSE LTD 272,063$9,080,0000.66%
Clal Insurance Enterprises Holdings Ltd 17,666$529,388,0000.57%
Migdal Insurance & Financial Holdings Ltd. 738,302$24,637,0000.48%
View complete list of UROGEN PHARMA LTD shareholders